{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T03:54:04Z","timestamp":1783569244812,"version":"3.55.0"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,1,20]],"date-time":"2021-01-20T00:00:00Z","timestamp":1611100800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004085","name":"Ministry of Education, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004085","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2016R1A5A2012284"],"award-info":[{"award-number":["2016R1A5A2012284"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.bbrc.2021.01.030","type":"journal-article","created":{"date-parts":[[2021,2,12]],"date-time":"2021-02-12T08:20:12Z","timestamp":1613118012000},"page":"1-7","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Myostatin inhibitor YK11 as a preventative health supplement for bacterial sepsis"],"prefix":"10.1016","volume":"543","author":[{"given":"Su Jin","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amal","family":"Gharbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joo Eun","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"In Duk","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeong Min","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2021.01.030_bib1","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1056\/NEJM200005043421806","article-title":"The acute respiratory distress syndrome","volume":"342","author":"Ware","year":"2000","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.bbrc.2021.01.030_bib2","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1097\/01.shk.0000054370.24363.ee","article-title":"Antibiotics improve survival and alter the inflammatory profile in a murine model of sepsis from Pseudomonas aeruginosa pneumonia","volume":"19","author":"Coopersmith","year":"2003","journal-title":"Shock"},{"key":"10.1016\/j.bbrc.2021.01.030_bib3","first-page":"499","article-title":"Proteasome proteolytic activity in skeletal muscle is increased in patients with sepsis","volume":"112","author":"Fredriksson","year":"2007","journal-title":"J\u00a0Clin Sci"},{"key":"10.1016\/j.bbrc.2021.01.030_bib4","article-title":"Lipopolysaccharide inhibits myogenic differentiation of C2C12 myoblasts through the Toll-like receptor 4-nuclear factor-\u03baB signaling pathway and myoblast-derived tumor necrosis factor-\u03b1","volume":"24","author":"Ono","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.bbrc.2021.01.030_bib5","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1038\/sj.bjc.6602780","article-title":"Expression of the ubiquitin-proteasome pathway and muscle loss in experimental cancer cachexia","volume":"93","author":"Khal","year":"2005","journal-title":"Br. J. Canc."},{"key":"10.1016\/j.bbrc.2021.01.030_bib6","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/0092-8674(93)90610-3","article-title":"The MyoD family and myogenesis: redundancy, networks, and thresholds","volume":"75","author":"Weintraub","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.bbrc.2021.01.030_bib7","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1096\/fj.10-176917","article-title":"Pharmacological inhibition of myostatin suppresses systemic inflammation and muscle atrophy in mice with chronic kidney disease","volume":"25","author":"Zhang","year":"2011","journal-title":"Faseb. J."},{"key":"10.1016\/j.bbrc.2021.01.030_bib8","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1083\/jcb.200407021","article-title":"Muscle expression of a local Igf-1 isoform protects motor neurons in an ALS mouse model","volume":"168","author":"Dobrowolny","year":"2005","journal-title":"J.\u00a0Cell Biol."},{"key":"10.1016\/j.bbrc.2021.01.030_bib9","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.clnu.2008.06.013","article-title":"Cachexia: a new definition","volume":"27","author":"Evans","year":"2008","journal-title":"Clin. Nutr."},{"key":"10.1016\/j.bbrc.2021.01.030_bib10","doi-asserted-by":"crossref","first-page":"7230","DOI":"10.1128\/MCB.23.20.7230-7242.2003","article-title":"Myostatin signals through a transforming growth factor beta-like signaling pathway to block adipogenesis","volume":"23","author":"Rebbapragada","year":"2003","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.bbrc.2021.01.030_bib11","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1096\/fj.07-8673com","article-title":"Transgenic expression of a myostatin inhibitor derived from follistatin increases skeletal muscle mass and ameliorates dystrophic pathology in mdx mice","volume":"22","author":"Nakatani","year":"2007","journal-title":"Faseb. J."},{"key":"10.1016\/j.bbrc.2021.01.030_bib12","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1248\/bpb.34.318","article-title":"(17\u03b1,20E)-17,20-[(1-Methoxyethylidene)bis(oxy)]-3-oxo-19-norpregna-4,20-diene-21-carboxylic Acid Methyl ester (YK11) is a partial agonist of the androgen receptor","volume":"34","author":"Kanno","year":"2011","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.bbrc.2021.01.030_bib13","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1248\/bpb.b13-00231","article-title":"Selective androgen receptor modulator, YK11, regulates myogenic differentiation of C2C12 myoblasts by follistatin expression","volume":"36","author":"Kanno","year":"2013","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.bbrc.2021.01.030_bib14","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1248\/bpb.b17-00748","article-title":"Selective androgen receptor modulator, YK11, up-regulates osteoblastic proliferation and differentiation in MC3T3-E1 cells","volume":"41","author":"Yatsu","year":"2018","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.bbrc.2021.01.030_bib15","doi-asserted-by":"crossref","first-page":"E1031","DOI":"10.1152\/ajpendo.00656.2010","article-title":"Increased energy expenditure and leptin sensitivity account for low fat mass in myostatin-deficient mice","volume":"300","author":"Choi","year":"2011","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.bbrc.2021.01.030_bib16","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/sj.gt.3303016","article-title":"Myostatin antisense RNA-mediated muscle growth in normal and cancer cachexia mice","volume":"15","author":"Liu","year":"2007","journal-title":"Gene Ther."},{"key":"10.1016\/j.bbrc.2021.01.030_bib17","doi-asserted-by":"crossref","first-page":"14938","DOI":"10.1073\/pnas.95.25.14938","article-title":"Organization of the human myostatin gene and expression in healthy men and HIV-infected men with muscle wasting","volume":"95","author":"Gonzalez-Cadavid","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.bbrc.2021.01.030_bib18","doi-asserted-by":"crossref","first-page":"27313","DOI":"10.1074\/jbc.M112.377960","article-title":"Specificity and structure of a high affinity activin receptor-like kinase 1 (ALK1) signaling complex","volume":"287","author":"Townson","year":"2012","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.bbrc.2021.01.030_bib19","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1002\/ana.21338","article-title":"A\u00a0phase I\/II trial of MYO-029 in adult subjects with muscular dystrophy","volume":"63","author":"Wagner","year":"2008","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bbrc.2021.01.030_bib20","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/387083a0","article-title":"Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member","volume":"387","author":"McPherron","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2021.01.030_bib21","doi-asserted-by":"crossref","first-page":"2859","DOI":"10.1001\/jama.288.22.2859","article-title":"Paresis acquired in the intensive care unit: a prospective multicenter study","volume":"288","author":"Bernard","year":"2002","journal-title":"J.\u00a0Am. Med. Assoc."},{"key":"10.1016\/j.bbrc.2021.01.030_bib22","doi-asserted-by":"crossref","first-page":"695","DOI":"10.3390\/biom10050695","article-title":"Differentiation of murine C2C12 myoblasts strongly reduces the effects of myostatin on intracellular signaling","volume":"10","author":"Juulia","year":"2020","journal-title":"Biomolecules"},{"key":"10.1016\/j.bbrc.2021.01.030_bib23","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1097\/CCM.0b013e3181e7c5c9","article-title":"A\u00a0randomized, double-blind, placebo-controlled trial of TAK-242 for the treatment of severe sepsis","volume":"38","author":"Rice","year":"2010","journal-title":"Crit. Care Med."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X21000668?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X21000668?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T12:00:24Z","timestamp":1757764824000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X21000668"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":23,"alternative-id":["S0006291X21000668"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2021.01.030","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Myostatin inhibitor YK11 as a preventative health supplement for bacterial sepsis","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2021.01.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}